References
- Andrews G, Page AC. Outcome measurements, outcome management and monitoring. Aust N Z J Psychiatry 2005; 39:649–651.
- Lishman WA. Endocrine diseases and metabolic disorders. Organic psychiatry: the psychological consequences of cerebral disorder, WA Lishman. Blackwell Science, Oxford 1998; 526–527
- Lee JW. An XXYY male with schizophrenia. Aust N Z J Psychiatry 1996; 30: 553–556
- Sorensen K, Nielsen J, Jacobsen P, Rolle T. The 48, XXYY syndrome. J Ment Defic Res 1978; 22: 197–205
- van Rijn S, Swaab H, Aleman A, Kahn RS. Klinefelter's syndrome (karyotype 47, XXY) and schizophrenia-spectrum pathology. Br J Psychiatry 2006; 189: 459–460
- van Rijn S, Swaab H, Aleman A, Kahn RS. Neurobiology of emotion and high risk for schizophrenia: role of the amygdala and the X-chromosome. Neurosci Biobehav Rev 2005; 3: 385–397
- Sommer I, Aleman A, Ramsey N, et al. Handedness, language lateralisation and anatomical asymmetry in schizophrenia. Meta-analysis. Br J Psychiatry 2001; 178: 344–351
- Crow TJ. Handedness, language lateralisation and anatomical asymmetry: relevance of protocadherin XY to hominid speciation and the aetiology of psychosis: point of view. Br J Psychiatry 2002; 181: 295–297
- Owen MJ, Williams NM, O'Donovan MC. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 2004; 1: 14–27
- Munafo MR, Thiselton DL, Clark TG, et al. Association of the NRGI gene and schizophrenia: a meta-analysis. Mol Psychiatry 2006; 11: 539–546
- Millar JK, Wilson-Annan JC, Anderson S, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415–1423